 The aim of the present study is to compare the effects of simvastatin 40 mg versus simvastatinezetimibe 1010 mg on sdLDL-C concentration. The primary efficacy endpoint will be changes in LDL subfraction profile i.e. mean LDL particle size, sdLDL-C levels at 3 months after treatment initiation. 